10/16/2023 Which is a contraindication for the administration of tissue plasminogen activator (t-pa)?Read NowCase studies that involved malpractice litigation in ischemic stroke and thrombolytic therapy were analyzed systematically. An extensive search of Medline, Embase, Westlaw, LexisNexis Legal, and Google Scholar databases was performed. Anecdotal data indicates that physicians are increasingly liable for administering and for failure to administer tPA. Intravenous tPA (tissue plasminogen activator) therapy remains underutilized in patients with Acute Ischemic Stroke (AIS).
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |